Liabilities / Assets
16th percentile
Tied with the lowest-debt nonprofits in its peer group.
Siviq Scores
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
0.00x
Liabilities / Revenue
16th percentile
Tied with the lowest-debt nonprofits in its peer group.
Net Margin
51st percentile
Higher net margin than 51% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
90th percentile
Faster asset growth than 90% of similar nonprofits.
Revenue Growth
50th percentile
Faster revenue growth than 50% of similar nonprofits.
Balance Sheet
Assets
Up$118,756
Up $40,244 (+51%) from 2022
Net Assets
Up$118,756
Up $50,922 (+75%) from 2022
Liabilities
Down$0
Down $10,678 (-100%) from 2022
Revenue And Expenses
Revenue
Up$1,162,802
Up $68,253 (+6.2%) from 2022
Expenses
Down$1,111,880
Down $290,122 (-21%) from 2022
Net Income
Up$50,922
Up $358,375 (+117%) from 2022
Historical Trend
Filing Detail Status
This 2023 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Jump To
Filing Snapshot
- Filing Period
- Jan 1, 2023 to Dec 31, 2023
Mission and Program Overview
Mission
Raise funds for leukemia and lymphoma research and for other charitable nonprofit organizations.
Document Assets
No mirrored PDF or thumbnail assets are attached yet.
Filings
Displayed year
2023 • Form 990Summary only. Only limited summary data is available for this year.
- Assets
- $118,756
- Liabilities
- $0
- Net assets
- $118,756
- Revenue
- $1,162,802
- Expenses
- $1,111,880
- Net income
- $50,922